Lindbrook Capital LLC Has $1.37 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Lindbrook Capital LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 32.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,246 shares of the exchange traded fund’s stock after selling 7,360 shares during the quarter. Lindbrook Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $1,373,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of XBI. Howard Capital Management Group LLC boosted its position in SPDR S&P Biotech ETF by 2.6% during the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after acquiring an additional 6,188 shares during the period. Graypoint LLC boosted its position in SPDR S&P Biotech ETF by 5.6% during the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 146 shares during the period. Advisor Resource Council acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth about $260,000. Verity Asset Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Verity Asset Management Inc. now owns 20,089 shares of the exchange traded fund’s stock valued at $1,985,000 after buying an additional 179 shares during the last quarter. Finally, Equitable Trust Co. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $211,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $87.82 on Thursday. The firm has a market cap of $5.79 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The stock has a 50-day simple moving average of $90.68 and a 200-day simple moving average of $95.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.